We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Screening Strategy Reduces Incidence of Immigration-Related Tuberculosis

By LabMedica International staff writers
Posted on 29 Mar 2015
Print article
Image: Mycobacterium tuberculosis culture revealing this organism’s typical morphologic characteristics of colorless rough surface, which are seen in M. tuberculosis colonial growth (Photo courtesy of Dr. George Kubica).
Image: Mycobacterium tuberculosis culture revealing this organism’s typical morphologic characteristics of colorless rough surface, which are seen in M. tuberculosis colonial growth (Photo courtesy of Dr. George Kubica).
Implementation of the culture-based algorithm may have substantially reduced the incidence of tuberculosis (TB) among newly arrived, foreign-born persons in the United States of America.

Immigration has a substantial effect on the incidence of TB, so immigrants and refugees bound for the USA are required to have overseas TB screening. Before 2007, a smear-based algorithm that could not diagnose smear-negative/culture-positive TB was used to screen this population.

Scientists at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) revised the screening strategy to use a more inclusive culture-based algorithm. They reviewed health records to determine the increase of smear-negative/culture-positive Mycobacterium tuberculosis or TB cases diagnosed overseas between 2007 and 2012 and compared that figure with the decline of reported TB cases among foreign-born persons within one year after arrival in the USA.

Of the 3,212,421 arrivals of immigrants and refugees from 2007 to 2012, a total of 1,650,961 (51.4%) were screened by the smear-based algorithm and 1,561,460 (48.6%) were screened by the culture-based algorithm. Among the 4,032 TB cases diagnosed by the culture-based algorithm, 2,195 (54.4%) were smear-negative/culture-positive. Before implementation (2002 to 2006), the annual number of reported cases among foreign-born persons within one year after arrival was relatively constant (range, 1,424 to 1,626 cases; mean, 1,504 cases), but decreased from 1,511 to 940 cases during implementation (2007 to 2012). During the same period, the annual number of smear-negative/culture-positive TB cases diagnosed overseas among immigrants and refugees bound for the USA by the culture-based algorithm increased from 4 to 629.

The authors concluded that the increased annual number of TB cases detected in immigrants and refugees closely matched in magnitude a decrease in the number reported TB cases, suggesting that the culture-based algorithm effectively reduced TB incidence. To further reduce the TB incidence in foreign-born populations, consideration should be given to expanding TB screening to students, exchange visitors, and temporary workers from countries with a high incidence of TB, as well as finding novel strategies to address the large numbers of foreign-born persons with latent TB infection The study was published on March 17, 2015, in the journal Annals of Internal Medicine.

Related Links:

[US] Centers for Disease Control and Prevention


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.